Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.38
-0.05 (-0.53%)
Sep 2, 2026, 11:16 AM EDT - Market open
Immatics Market Cap
Immatics has a market cap or net worth of $1.28 billion as of September 2, 2026. Its market cap has increased by 107.22% in one year.
Market Cap
1.28B
Enterprise Value
849.45M
1-Year Change
107.22%
Ranking
Category
Stock Price
$9.38
ChartMarket Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.28B, an increase of 643.28%. That is a compound annual growth rate of 29.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.28B | -8.92% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.36B |
| Omeros | 1.36B |
| Vor Biopharma | 1.34B |
| Jade Biosciences | 1.34B |
| ORIC Pharmaceuticals | 1.34B |
| Alpha Tau Medical | 1.29B |
| MoonLake Immunotherapeutics | 1.29B |
| MannKind | 1.28B |